Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow. Pete O’Heeron, founder, chairman and CEO of FibroBiologics, has a ...
CRISPR/Cas9 genome editing is fast becoming the essential tool for industrial microbial production and chemical synthesis by virtue of its speed, precision, and versatility. CRISPR can drastically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results